Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Grant or award Chief Scientific Officer acquired 595 shares (grant or award)
  2. 4 Grant or award Chief Operating Officer acquired 861 shares (grant or award)
  3. 4 Grant or award Chief Development Officer acquired 822 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 1,275 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 1,371 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 1,371 shares (grant or award)
  7. 4 Exercise or conversion Chief Medical Officer acquired 25,000 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Chief Medical Officer bought 4,500 shares at an average $11.01 ($49,558)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 18 · 356 filings